SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-099826
Filing Date
2023-09-12
Accepted
2023-09-12 06:03:52
Documents
6
Period of Report
2023-10-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2325301-2_def14a.htm DEF 14A 508197
2 GRAPHIC tm2325301d1_pre14aimg001.jpg GRAPHIC 4145
3 GRAPHIC tm2325301d1_pre14aimg002a.jpg GRAPHIC 96942
4 GRAPHIC tm2325301d1_pre14aimg003a.jpg GRAPHIC 80792
5 GRAPHIC tmb-20230831xcoverg001.jpg GRAPHIC 235002
6 GRAPHIC tmb-20230831xcoverg002.jpg GRAPHIC 157092
  Complete submission text file 0001104659-23-099826.txt   1300702
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: DEF 14A | Act: 34 | File No.: 001-37846 | Film No.: 231248940
SIC: 3841 Surgical & Medical Instruments & Apparatus